Princeton Global Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$121K Sell
570
-8
-1% -$1.57K 0.02% 273
2026
Q1
$113K Buy
578
+4
+0.7% +$777 0.02% 265
2025
Q4
$99.6K Buy
574
+182
+46% +$33.1K 0.02% 267
2025
Q3
$74.7K Sell
392
-3
-0.8% -$532 0.01% 278
2025
Q2
$71K Buy
395
+57
+17% +$9.9K 0.01% 270
2025
Q1
$57.3K Buy
338
+1
+0.3% +$164 0.01% 284
2024
Q4
$50.8K Buy
337
+2
+0.6% +$311 0.01% 315
2024
Q3
$52K Buy
335
+2
+0.6% +$299 0.01% 315
2024
Q2
$45.6K Buy
333
+1
+0.3% +$137 0.01% 304
2024
Q1
$44.1K Buy
332
+2
+0.6% +$259 0.01% 282
2023
Q4
$45.5K Buy
330
+2
+0.6% +$263 0.01% 271
2023
Q3
$40K Buy
328
+2
+0.6% +$266 0.01% 271
2023
Q2
$45.9K Buy
326
+1
+0.3% +$138 0.01% 268
2023
Q1
$45.9K Buy
325
+2
+0.6% +$286 0.01% 270
2022
Q4
$51K Buy
323
+1
+0.3% +$144 0.02% 239
2022
Q3
$39K Buy
322
+2
+0.6% +$263 0.01% 257
2022
Q2
$43K Hold
320
0.01% 263
2022
Q1
$44K Hold
320
0.01% 278
2021
Q4
$55K Hold
320
0.02% 248
2021
Q3
$46K Hold
320
0.01% 261
2021
Q2
$42K Hold
320
0.01% 267
2021
Q1
$41K Hold
320
0.01% 258
2020
Q4
$38K Hold
320
0.01% 263
2020
Q3
$37K Buy
320
+160
+100% +$18.9K 0.01% 235
2020
Q2
$18K Hold
160
0.01% 362
2020
Q1
$13K Buy
+160
New +$16.6K 0.01% 360

Other funds holding DGX

Princeton Global Asset Management's DGX Position: Q2 2026 in Review

Princeton Global Asset Management reduced its Quest Diagnostics (DGX) stake by 1.4% in Q2 2026, selling an estimated $1.57K and leaving 570 shares worth $121K. The position accounts for 0.02% of the portfolio, ranked #273.

Princeton Global Asset Management first reported a position in DGX in Q1 2020 and has held it in 26 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Princeton Global Asset Management held 570 shares of Quest Diagnostics worth $121K as of Q2 2026.
  • Princeton Global Asset Management sold 8 Quest Diagnostics shares in Q2 2026, an estimated $1.57K.
  • Quest Diagnostics made up 0.02% of Princeton Global Asset Management's portfolio in Q2 2026, its #273 holding.
  • Princeton Global Asset Management first reported a position in Quest Diagnostics in Q1 2020 and has held it in 26 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.